STERIS (STE) 10-K Summary — Year Ended Mar 31, 2025
The company provides products and services for infection prevention and surgical support. For the most recent annual period, revenue and operating cash flow increased compared to the prior year.
Key takeaway
Year ended Mar 31, 2025 · FY2026 10-K
The company provides products and services for infection prevention and surgical support. For the most recent annual period, revenue and operating cash flow increased compared to the prior year.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$5.5B
Revenue reported for the fiscal year.
Operating income
$866.6M
Income from operations reported for the year.
Net income
$614.6M
Net income reported for the year.
Operating cash flow
$1.1B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $1.2B | n/a |
| Dec 31, 2023 | $1.3B | +4.8% |
| Mar 31, 2024 | $5.1B | +296.0% |
| Mar 31, 2025 | $5.5B | +6.2% |
Business overview
STERIS plc operates in segments related to healthcare, pharmaceutical, and medical device customers, offering sterilization, surgical equipment, and consumables. The business overview references general information about its segments and operations. The filing does not provide further detail on specific products or markets.
Financial performance
Revenue and operating income for the year were higher than the prior year. Net income also increased. Operating cash flow improved compared to the previous annual period.
Material risks
The filing identifies risk factors in Item 1A, but the supplied context does not include the specific text of those risks. No material risks can be stated from the available information. Readers should refer to the full risk factor section for details.
Liquidity and capital
The filing discusses liquidity and capital resources, including capital expenditures and material future cash obligations. No specific capital-allocation themes or changes are described in the supplied context.
What to watch
Monitor any changes in the company's revenue growth rate or operating cash flow trend in the next annual filing.